Up next

Autoplay

Dr. James C. Yao on Everolimus in Pancreatic Neuroendocrine Tumors

13 Views • 07/13/23
Share
Embed
administrator
administrator
Subscribers
0

James C. Yao, MD, discusses the administration of everolimus (Afinitor) for patients with pancreatic neuroendocrine tumors

For more resources and information regarding targeted therapies in cancer: http://targetedhc.com/

Show more
0 Comments sort Sort By
Facebook Comments

Up next

Autoplay